Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR 2,464.55
-48.05 (-1.91%)
At close: May 6, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 13.59 billion as of May 6, 2026. Its market cap has increased by 326.91% in one year.
Market Cap
13.59B
Enterprise Value
15.21B
Revenue
5.91B
Ranking
n/a
PE Ratio
35.01
Stock Price
2,464.55
Market Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.41M to 13.59B, an increase of 46,104.05%. That is a compound annual growth rate of 83.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 13.59B | 82.31% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 16.49B |
| Kwality Pharmaceuticals | 16.41B |
| Venus Remedies | 13.08B |
| Syncom Formulations (India) | 12.91B |
| Lincoln Pharmaceuticals | 12.84B |
| TTK Healthcare | 12.82B |
| Shukra Pharmaceuticals | 12.73B |
| Fermenta Biotech | 9.16B |